Salk Institute

Technologies Available for Licensing

Search Results - immunotherapies

2 Results Sort By:
Oncolytic Viral Cancer Immunotherapy
Oncolytic Viral Cancer Immunotherapy Modular construction of targeted, systemically delivered oncolytic adenovirus for immunotherapy of cancer. INVENTION: Oncolytic viruses are exquisite tumor-selective, multi-mechanistic antitumor agents that can kill cancer cells, not just through direct oncolysis, but also via immunogenic cell death. These ...
Published: 4/9/2014   |   Inventor(s):  
Keywords(s): Adenovirus, Cancer Therapeutics, Cancer Vaccines, Immunotherapies, Malignancy, Oncology, Oncolytic Therapy, O'Shea, Targeted Therapies, Viral Vectors
Category(s): Oncology
Adenoviral Assembly Method
Modular Adenovirus Assembly Platform Custom, rapid and systematic assembly of recombinant adenoviral genomes from modular parts. INVENTION: Although adenoviral vectors are regularly used for the delivery of exogenous DNA to mammalian cells for basic science research, vaccines and gene therapy, the potential of adenoviral vectors in several ap...
Published: 4/9/2014   |   Inventor(s):  
Keywords(s): Adenovirus, Cancer Diagnostics, Cancer Therapeutics, Cancer Vaccines, DNA Virus, Gene Delivery, Gene Expression, Gene Therapy, Immunotherapies, Oncology, Oncolytic Therapy, O'Shea, Targeted Therapies, Vaccine, Viral Vectors, Virus
Category(s): Diagnostics/Biomarkers, Drug Discovery, Oncology, Regenerative Medicine, Research Reagents, Vaccines
© 2017. All Rights Reserved. Powered by Inteum      

Get Involved
Join our online community
Facebook    Facebook
Twitter    Twitter
YouTube    YouTube
RSS    RSS
Contact
Salk Institute for Biological Studies
Street: 10010 North Torrey Pines Rd
City: La Jolla, CA 92037
Email: webrequest@salk.edu
Phone: 858.453.4100
Charity Navigator Rating
© Copyright 2012 Salk Institute for Biological Studies About Scientists & Research News & Media Events Support